Who
David Weill
Director
Company insider
Files Form 4 as: Director, TransMedics Group.
In numbers
- Trades disclosed
- 33
- Buys
- 3
- Sells
- 7
- Bought
- $543K
- Sold
- $4.0M
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 11 Nov 2019
- Last trade
- 11 Sep 2026
- Last filed
- 14 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 11 Sep 2026filed 14 Sep 2026 | TMDX TransMedics GroupMedical Devices | SEC FORM 4 Bought | $109K1,336 at $81.63 | filing |
| 11 Sep 2026filed 14 Sep 2026 | TMDX TransMedics GroupMedical Devices | SEC FORM 4 Bought | $109K1,336 at $81.63 | filing |
| 20 May 2026filed 22 May 2026 | TMDX TransMedics GroupMedical Devices | SEC FORM 4 Code A | —2,922 at $0.00 | filing |
| 20 May 2026filed 22 May 2026 | TMDX TransMedics GroupMedical Devices | SEC FORM 4 Code A | —2,922 at $0.00 | filing |
| 4 Mar 2026filed 6 Mar 2026 | TMDX TransMedics GroupMedical Devices | SEC FORM 4 Code M | $51K3,571 at $14.20 | filing |
| 4 Mar 2026filed 6 Mar 2026 | TMDX TransMedics GroupMedical Devices | SEC FORM 4 Sold | $524K3,571 at $146.82 | filing |
| 4 Mar 2026filed 6 Mar 2026 | TMDX TransMedics Groupoption or derivative · Medical Devices | SEC FORM 4 Code M | —3,571 at $0.00 | filing |
| 4 Mar 2026filed 6 Mar 2026 | TMDX TransMedics Groupoption or derivative · Medical Devices | SEC FORM 4 Code M | —3,571 at $0.00 | filing |
| 4 Mar 2026filed 6 Mar 2026 | TMDX TransMedics GroupMedical Devices | SEC FORM 4 Code M | $51K3,571 at $14.20 | filing |
| 4 Mar 2026filed 6 Mar 2026 | TMDX TransMedics GroupMedical Devices | SEC FORM 4 Sold | $524K3,571 at $146.82 | filing |
| 3 Dec 2025filed 5 Dec 2025 | TMDX TransMedics Groupoption or derivative · Medical Devices | SEC FORM 4 Code M | —5,000 at $0.00 | filing |
| 3 Dec 2025filed 5 Dec 2025 | TMDX TransMedics GroupMedical Devices | SEC FORM 4 Code M | $71K5,000 at $14.20 | filing |
| 3 Dec 2025filed 5 Dec 2025 | TMDX TransMedics GroupMedical Devices | SEC FORM 4 Sold | $693K5,000 at $138.64 | filing |
| 23 May 2025filed 23 May 2025 | TMDX TransMedics GroupMedical Devices | SEC FORM 4 Sold | $91K732 at $123.88 | filing |
| 22 May 2025filed 23 May 2025 | TMDX TransMedics GroupMedical Devices | SEC FORM 4 Code A | —2,134 at $0.00 | filing |
| 29 May 2024filed 31 May 2024 | TMDX TransMedics GroupMedical Devices | SEC FORM 4 Sold | $169K1,193 at $141.65 | filing |
| 23 May 2024filed 28 May 2024 | TMDX TransMedics Groupoption or derivative · Medical Devices | SEC FORM 4 Code A | —1,154 at $0.00 | filing |
| 23 May 2024filed 28 May 2024 | TMDX TransMedics GroupMedical Devices | SEC FORM 4 Code A | —732 at $0.00 | filing |
| 10 May 2024filed 14 May 2024 | TMDX TransMedics GroupMedical Devices | SEC FORM 4 Sold | $325K2,500 at $129.82 | filing |
| 29 Aug 2023filed 30 Aug 2023 | TMDX TransMedics GroupMedical Devices | SEC FORM 4 Bought | $155K2,500 at $62.00 | filing |
News
TransMedics Director David Weill Purchases $109,000 of Stock -- Should Investors Buy Too?fool.com · 29 Sep 2026TransMedics Group (NASDAQ:TMDX) and Cerus (NASDAQ:CERS) Head-To-Head ContrastTMDX · themarketsdaily.com · 13 Oct 2026TransMedics Group (NASDAQ:TMDX) Research Coverage Started at BarclaysTMDX · themarketsdaily.com · 10 Oct 2026
1 headline in the last 90 days name David Weill; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.